Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation

BACKGROUND: Dysferlinopathy refers to a group of muscle diseases with progressive muscle weakness and atrophy caused by pathogenic mutations of the DYSF gene. The pathogenesis remains unknown, and currently no specific treatment is available to alter the disease progression. This research aims to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yan, Li, Ying-hui, Chen, Kai, Zhu, Chun-yan, Bai, Jia-ying, Xiao, Feng, Tan, Song, Zeng, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530905/
https://www.ncbi.nlm.nih.gov/pubmed/36203997
http://dx.doi.org/10.3389/fneur.2022.998251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530905/
https://www.ncbi.nlm.nih.gov/pubmed/36203997
http://dx.doi.org/10.3389/fneur.2022.998251

Ejemplares similares